Regarding their characteristics showing high CB1 affinity and overall high cannabimimetic activity, those new derivatives represent promising tools in the research of neurological diseases and especially epilepsy, which needs to be established in future studies [50,185]. The gene discussed is CNR1; the disease is epilepsy.